These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16740093)

  • 1. Pharmacokinetics of the opioid antagonist N-methylnaltrexone and evaluation of its effects on gastrointestinal tract function in horses treated or not treated with morphine.
    Boscan P; Van Hoogmoed LM; Pypendop BH; Farver TB; Snyder JR
    Am J Vet Res; 2006 Jun; 67(6):998-1004. PubMed ID: 16740093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effects of the opioid agonist morphine on gastrointestinal tract function in horses.
    Boscan P; Van Hoogmoed LM; Farver TB; Snyder JR
    Am J Vet Res; 2006 Jun; 67(6):992-7. PubMed ID: 16740092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
    Foss JF
    Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of morphine and methylnaltrexone on gastrointestinal pain in healthy male participants.
    Brokjaer A; Olesen AE; Christrup LL; Dahan A; Drewes AM
    Neurogastroenterol Motil; 2015 May; 27(5):693-704. PubMed ID: 25810023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylnaltrexone crosses the blood-brain barrier and attenuates centrally-mediated behavioral effects of morphine and oxycodone in mice.
    Walentiny DM; Komla E; Moisa LT; Mustafa MA; Poklis JL; Akbarali HI; Beardsley PM
    Neuropharmacology; 2021 Mar; 185():108437. PubMed ID: 33316279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health.
    Wong BS; Rao AS; Camilleri M; Manabe N; McKinzie S; Busciglio I; Burton DD; Ryks M; Zinsmeister AR
    Aliment Pharmacol Ther; 2010 Oct; 32(7):884-93. PubMed ID: 20839388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial.
    Yuan CS; Foss JF; O'Connor M; Toledano A; Roizen MF; Moss J
    Clin Pharmacol Ther; 1996 Apr; 59(4):469-75. PubMed ID: 8612393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time.
    Yuan CS; Foss JF; Osinski J; Toledano A; Roizen MF; Moss J
    Clin Pharmacol Ther; 1997 Apr; 61(4):467-75. PubMed ID: 9129564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-release but not immediate-release and subcutaneous methylnaltrexone antagonizes the loperamide-induced delay of whole-gut transit time in healthy subjects.
    Kolbow J; Modess C; Wegner D; Oswald S; Maritz MA; Rey H; Weitschies W; Siegmund W
    J Clin Pharmacol; 2016 Feb; 56(2):239-45. PubMed ID: 26313157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of methylnaltrexone on guinea pig gastrointestinal motility.
    Anselmi L; Huynh J; Vegezzi G; Sternini C
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Apr; 386(4):279-86. PubMed ID: 23361094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial.
    Yuan CS; Wei G; Foss JF; O'Connor M; Karrison T; Osinski J
    J Pharmacol Exp Ther; 2002 Jan; 300(1):118-23. PubMed ID: 11752106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of peripheral opioid receptors by methylnaltrexone does not prevent morphine tolerance in rats.
    Blomqvist KJ; Dudek KA; Viisanen H; Mätlik K; Ahlström FHG; Laitila J; Kalso EA; Rauhala PV; Lilius TO
    J Neurosci Res; 2022 Jan; 100(1):329-338. PubMed ID: 32459013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogs.
    Foss JF; Bass AS; Goldberg LI
    J Clin Pharmacol; 1993 Aug; 33(8):747-51. PubMed ID: 8408737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of the effect of the opioid antagonist N-methylnaltrexone on motility of the equine jejunum and pelvic flexure.
    van Hoogmoed LM; Boscan PL
    Equine Vet J; 2005 Jul; 37(4):325-8. PubMed ID: 16028621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time.
    Yuan CS; Foss JF; O'Connor M; Karrison T; Osinski J; Roizen MF; Moss J
    Clin Pharmacol Ther; 2000 Apr; 67(4):398-404. PubMed ID: 10801249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation.
    Singleton PA; Moreno-Vinasco L; Sammani S; Wanderling SL; Moss J; Garcia JG
    Am J Respir Cell Mol Biol; 2007 Aug; 37(2):222-31. PubMed ID: 17395891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans.
    Yuan CS; Doshan H; Charney MR; O'connor M; Karrison T; Maleckar SA; Israel RJ; Moss J
    J Clin Pharmacol; 2005 May; 45(5):538-46. PubMed ID: 15831777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic profile of epidurally administered methylnaltrexone, a novel peripheral opioid antagonist in a rabbit model.
    Murph DB; El Behiery H; Chan VW; Foss JF
    Br J Anaesth; 2001 Jan; 86(1):120-2. PubMed ID: 11575386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Buprenorphine, Methylnaltrexone, and Their Combination on Gastrointestinal Transit in Healthy New Zealand White Rabbits.
    Martin-Flores M; Singh B; Walsh CA; Brooks EP; Taylor L; Mitchell LM
    J Am Assoc Lab Anim Sci; 2017 Mar; 56(2):155-159. PubMed ID: 28315644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation.
    Shaiova L; Rim F; Friedman D; Jahdi M
    Palliat Support Care; 2007 Jun; 5(2):161-6. PubMed ID: 17578067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.